Orthopedic Biomaterial Market to Grow Exponentially with over 10%

Pune, India, October, 2018 /MRFR Press Release/- Market Research Future published a half-cooked research report on “Global Orthopedic Biomaterial Market Research Report - Forecast to 2023” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.

The orthopedic biomaterial market is growing pervasively, witnessing an exponential growth backed by the increasing investments in the R&D activities. Healthcare segment extensively absorbs orthopedic biomaterial for a range of medical applications from medicines to implants.  Over the past decade, orthopedic biomaterials have evolved greatly. Combining medicine, biology, physics, and chemistry orthopedic biomaterials have presented the world with the regenerative bone and tissue engineering. 

Acknowledging the kind of traction gained by this market, Market Research Future (MRFR) in its recently published a study report asserts that the global orthopedic biomaterial market is projected to accrue voluminously by 2023 registering a phenomenal CAGR of 10.5% during the review period (2017 to 2023).

Additional factors such as growing population and urbanization worldwide are fostering the market growth. Improving economic conditions that enable access to the quality life & the improved healthcare provides impetus to the market growth. Seminal efforts &investments put in the development of innovative biomaterials, by the key market players are paying off well, fuelling the market growth. Also, initiatives taken by the Government are playing a major role in fostering the market growth.

On the other hand, factors such as low awareness among people about the advantages of these materials along with the high cost associated with the orthopedic biomaterial are likely to impede the market growth. Also, the skepticism of physicians towards the advancement & efficacies of these implants affects the market growth negatively. However, the demand for sophisticated implants by the physicians and patients, in turn, would contribute to the market growth to a great deal.

Access Report @  https://www.marketresearchfuture.com/reports/orthopedic-biomaterial-market-415

Global Orthopedic Biomaterial Market   - Segmentations

The MRFR analysis is segmented into four key dynamics for enhanced understanding.

By Types              : Metals (Titanium Alloy, Stainless Steel, Cobalt Alloy, and others.), and Non- Metal (Polymeric (polyester, silicone, polyethylene, polymethylmethacrylate (PMMA), others.), Natural Biomaterials, and Ceramic (alumina, zirconium dioxide, calcium phosphate, carbon, others.), among others.

By Applications   : Joint Replacement (shoulder, elbow, hip and, knee replacement, among others.), Tissue Fixation (suture anchors, interference screws, and others.), Fracture Fixation Devices (screws, plates for bones, rods, and others), and Spine Implants among others.

By End-Users       : Hospitals and Clinics and Specialty Centers among others.

 By Regions           :  North America, Europe, APAC, and the Rest-of-the-World.

Global Orthopedic Biomaterial Market   - Geographical Analysis

The North America market dominates the global orthopedic biomaterial market owing to the increasing healthcare expenditure followed by Europe and the Asia Pacific. North America market for orthopedic biomaterial is expected to continue with its dominance in the years to come owing to the favorable government regulations coupled with the increasing integration of orthopedic biomaterial in the region.

Simultaneously, the increasing prevalence of different orthopedic surgeries, along with the increasing geriatric populace boost the market growth in the region, leading to an increase in patient population. Furthermore, increasing awareness among the people, towards the benefits of biodegradable products and the rising demand for technologically advanced treatments and products enhance the growth of the orthopedic biomaterial market in North America.

The Europe region accounts for the second-largest orthopedic biomaterial market attributing to the increased research & development activities in the field backed by the government support and funds. The market is expected to grow due to the availability of innovative treatment facilities and rising research activities in orthopedic biomaterials for nanotechnology. Moreover, increasing cases in orthopedic surgeries along with the rising population awareness regarding keeping good health is fostering the market growth in the region. 

Whereas attributing to the huge population and the burgeoning medical treatment market in the region, Asia-Pacific market is emerging as the fastest growing market for orthopedic biomaterial. Growing markets of India, China, and Brazil backed by the increasing consumers’ awareness & improved lifestyle provide impetus to the market growth. Besides, the improved economy in the region presages the potential this market holds to grow further, creating the opportunities in the orthopedic biomaterial market during the forecast period.

On the other hand, the Middle East & Africa market witnesses impedimental growth due to the unmet medical needs aroused due to the unavailability of funds, limited medical facilities and the poor political conditions in Africa.

Global Orthopedic Biomaterial Market   - Competitive Landscape

Orthopedic biomaterial market demonstrates a high growth potential which is likely to attract many entrants to the market resultantly, intensifying the competition further. Manufacturers strive to develop innovative materials, and best practices. Incorporating acquisition, collaboration, partnership, and expansion the well-established players gain the competitive advantage to maintain their market position. Also, they make substantial investments in manufacturing & expansion programme. Expansions help in reducing logistic cost and increase production capacities and potential to fetch larger turnovers.

Key Players:

The fervent players leading the global orthopedic biomaterial market include CERADYNE, CoorsTek Inc., Straumann, Kyocera Corporation, Stryker, 3M ESPE, Materion Corporation, Nobel Biocare Services AG, DePuy Synthes, and Morgan Advanced Materials.

Industry/ Innovation /Related News:

August 9, 2018 – PolarityTE, Inc. (US), commercial-stage biotechnology and regenerative biomaterials company announced preclinical large animal model results for their new product, OsteoTE, which shows promise for bone regeneration. The researchers, during the preclinical studies, found that OsteoTE not only recapitulated the cortical and cancellous architecture of native uninjured bone but also regenerated bone with function and composition reflective of native bone.

OsteoTE can especially be useful in the case of a severe traumatic orthopedic injury where the doctor has to try to span a gap within a tibia, femur or humerus. Besides, OsteoTE finds application in craniofacial, orthopedic, neurosurgical, spine, and foot/ankle surgeries.